University Hospital, Grenoble
Clinical trials sponsored by University Hospital, Grenoble, explained in plain language.
-
Precision radiation boost for prostate cancer: first human test
Disease control OngoingThis study tests a new way to deliver extra radiation directly to prostate tumors using a 3D ultrasound guidance system. Fifteen men with low- or favorable intermediate-risk prostate cancer will receive standard brachytherapy plus up to 4 additional iodine-125 implants placed pre…
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated May 17, 2026 02:26 UTC
-
New combo therapy targets Hard-to-Treat liver cancer
Disease control TerminatedThis early-stage study tests whether adding an experimental drug called NP137 to the standard two-drug therapy (Atezolizumab and Bevacizumab) can improve outcomes for people with advanced liver cancer that cannot be removed by surgery. About 43 adults with unresectable hepatocell…
Phase: PHASE1 • Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated May 17, 2026 02:23 UTC
-
Ultrasound may let mild head injury patients skip hospital stay
Diagnosis OngoingThis study tests whether a simple ultrasound of the brain's blood vessels can safely identify mild traumatic brain injury patients who can go home right from the emergency room. About 550 adults with mild head injuries will be randomly assigned to either the ultrasound-based deci…
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Diagnosis
Last updated May 13, 2026 16:02 UTC